Tumor induction and tissue atrophy in mice lacking E2F-1

Cell

Volumn 85, Issue 4, 1996, Pages 537-548

  Yamasaki, Lili ^a   Jacks, Tyler ^b   Bronson, Roderick ^c   Goillot, Evelyne ^a   Harlow, Ed ^a   Dyson, Nicholas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TESTIS ATROPHY; TUMOR SUPPRESSOR GENE;

EID: 0029888359     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81254-4     Document Type: Article

References (76)

1. Adnane, J., Shao, Z., and Robbins, P.D. (1995). The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270, 8837-8843.
2. Beijersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlee, L., Voorhoeve, P.M., and Bernards, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
3. Blake, M.C., and Azizkhan, J.C. (1989). Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
4. Bremner, R., Cohen, B.L., Sopta, M., Hamel, P.A., Ingles, C.J., Gallie, B.L., and Phillips, R.A. (1995). Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15, 3256-3265.
5. Bronson, R.T. (1990). Chapter 17: Rate of occurrence of lesions in 20 inbred and hybrid genotypes of rats and mice sacrificed at 6 month intervals during the first years of life. In Genetic Effects on Aging II, D.E. Harrison, ed. (Caldwell, New Jersey: Telford Press, Inc.), pp. 279-358.
6. Bronson, R.T., and Lipman, R.D. (1991). Reduction in rate of occurrence of age related lesions in dietary restricted laboratory mice. Growth Dev. Aging 55, 169-184.
7. Capecchi, M.R. (1989). Altering the genome by homologous recombination. Science 244, 1288-1293.
8. Clarke, A., Maandag, E., van Roon, M., van der Lugt, N., van der Valk, M., Hooper, M., Berns, A., and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
9. Dobrowolski, S.F., Stacey, D.W., Harter, M.L., Stine, J.T., and Hiebert, S.W. (1994). An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9, 2605-2612.
10. Duhl, D.M., Stevens, M.E., Vrieling, H., Saxon, P.J., Miller, M.W., Epstein, C.J., and Barsh, G.S. (1994). Pleiotropic effects of the mouse lethal yellow (Ay) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion RNAs. Development 120, 1695-1708.
11. Duronio, R.J., O'Farrell, P.H., Xie, J.-E., Brook, A., and Dyson, N. (1995). The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9, 1445-1455.
12. Dynlacht, B.D., Brook, A., Dembski, M.S., Yenush, L., and Dyson, N. (1994a). DNA-binding and trans-activation properties by Drosophila E2F and DP proteins. Proc. Natl. Acad. Sci. USA 91, 6359-6363.
13. Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. (1994b). Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes Dev. 8, 1772-1786.
14. Field, S.J., Tsai, F.-Y., Kuo, R., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 Functions in mice to promote apoptosis and suppress proliferation. Cell, this issue.
15. Flemington, E.K., Speck, S.H., and Kaelin, W.G. (1993). E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90, 6914-6918.
16. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z.X., Xu, G., Wydner, K.L., DeCaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8, 2665-2679.
17. Gu, W., Schneider, J.W., Condorelli, G., Kaushai, S., Mahdavi, V., and Nadal-Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
18. Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring Harbor Press).
19. Helin, K., Lees, J.A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A. (1992). A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350.
20. Helin, K., Harlow, E., and Fattaey, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508.
21. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., van 'T Veer, L., and Bernards, R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089.
22. Horowitz, J.M., and Udvadia, A.J. (1996). Regulation of transcription by the Retinoblastoma (Rb) protein. Mol. Cell. Diff., in press.
23. Hsiao, K.-M., McMahon, S.L., and Farnham, P.J. (1994). Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8, 1526-1537.
24. Hu, N., Gutsmann, A., Herbert, D.C., Bradley, A., Lee, W.-H., and Lee, E.H.-H.P. (1994). Heterozygous rb-1/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-1027.
25. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 573-582.
26. Ivey-Hoyle, M., Conroy, R., Huber, H., Goodhart, P., Oliff, A., and Heinbrook, D.C. (1993). Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell Biol. 13, 7802-7812.
27. Jacks, T., Fazeli, A., Schmitt, E., Bronson, R., Goodell, M., and Weinberg, R. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
28. Jacks, T., Shih, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A., and Weinberg, R.A. (1994). Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nature Genetics 7, 353-361.
29. Johnson, D.G., Schwartz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352.
30. Johnson, D.G., Cress, W.D., Jakoi, L., and Nevins, J.R. (1994a). Oncogenic capacity of the E2F-1 gene. Proc. Natl. Acad. Sci. USA 91, 12823-12827.
31. Johnson, D.G., Ohtani, K., and Nevins, J.R. (1994b). Autoregulatory control of E2F-1 expression in response to positive and negative regulators of cell cycle expression. Genes Dev. 8, 1514-1525.
32. Jooss, K., Lam, E.W.-F., Bybee, A., Girlin, R., Muller, R., and La Thangue, N.B. (1995). Proto-oncogenic properties of the DP family of proteins. Oncogene 10, 1529-1536.
33. Kaelin, W.G., Jr., Krek, W., Sellers, W.R., DeCaprio, J.A., Ajchenbaum, F., Fuchs, C.S., Chittenden, T., Li, Y., Farnham, P.J., Blanar, M.A., Livingston, D.M., and Flemington, E.K. (1992). Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351-364.
34. Kamb, A. (1995). Cell cycle regulators and cancer. Trends Genetics 11, 136-140.
35. Kowalik, T.F., DeGregori, J., Schwarz, J.K., and Nevins, J.R. (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491-2500.
36. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.G., Jr., and Livingston, D.M. (1994). Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172.
37. Lam, E.W.-F., and Watson, R.J. (1993). An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12, 2705-2713.
38. La Thangue, N.B. (1994). DTRF1/E2f: an extending family of heteridimeric factors implicated in cell cycle control. Trends Biochem. Sci. 19, 108-114.
39. Lee, E.Y.-H.P., Chang, C.-Y., Hu, N., Wang, Y.-C.J., Lai, C.-C., Herrup, K., Lee, W.-H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
40. Lee, E.Y.-H.P., Hu, N., Yuan, S.-S.F., Cox, L.A, Bradley, A., Lee, W.-H., and Herrup, K. (1994). Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008-2021.
41. Lees, J.A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., and Helin, K. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
42. Li, Y., Slansky, J.E., Myers, D.J., Drinkwater, N.R., Kaelin, W.G., and Farnham, P.J. (1994). Cloning, chromosomal location, and characterization of mouse E2F1. Mol. Cell. Biol. 14, 1861-1869.
43. Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
44. Means, A.L., Slansky, J.E., McMahon, S.L., Knuth, M.W., and Farnham, P.J. (1992). The HIP binding site is required for growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 12, 1054-1063.
45. Michaud, E.J., Bultman, S.J., Klebig, M.L., van Vugt, M.J., Stubbs, L.J., Russell, L.B., and Woychik, R.P. (1994). A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc. Natl. Acad. Sci. USA 91, 2562-2566.
46. Muller, R. (1995). Transcriptional regulation during the mammalian cell cycle. Trends Genetics 11, 173-178.
47. Neuman, E., Flemington, E.K., Sellers, W.R., and Kaelin, W.G. (1994). Transcription of the E2F1 gene is rendered cell cycle-dependent by E2F DNA binding sites within its promoter. Mol. Cell. Biol. 14, 6607-6615.
48. Nevins, J.R. (1992). E2F; a link betwen the Rb Tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
49. Ohtani, K., and Nevins, J.R. (1994). Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14, 1603-1612.
50. Qin, X.-Q., Livingston, D.M., Kaelin, W.G., Jr., and Adams, P. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
51. Qin, X.-Q., Livingston, D.M., Ewen, M., Sellers, W.R., Arany, Z., and Kaelin, W.G. (1995). The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15, 742-755.
52. Riley, D.J., Lee, E.Y.-H.P., and Lee, W.-H. (1994). The retinoblastoma protein: more than a tumor suppressor. Ann. Rev. Cell Biol. 10, 1-29.
53. Russell, L.D., Ettlin, R.A., SinhaHikim, A.P., and Clegg, E.D. (1990). Histological and Histopathological Evaluation of the Testis, 1st Edition (Clearwater, Florida: Cache River Press).
54. Saito, M., Helin, K., Valentine, M.B., Griffith, B.B., Willman, C.L., Harlow, E., and Look, AT.(1995). Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Genomics 25, 130-138.
55. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R.A. (1995). E2F-4 and E2F-5, two novel members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
56. Schneider, J.W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264, 1467-1471.
57. Sellers, W.R., Rodgers, J.W., and Kaelin, W.G. (1995). A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92, 11544-11548.
58. Shan, B., and Lee, W.-H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173.
59. Shan, B., Zhu, X., Chen, P.-L., Durfee, T., Yang, Y., Sharp, D., and Lee, W.-H. (1992). Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12, 5620-5631.
60. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-556.
61. Singh, P., Wong, S.H., and Hong, W. (1994). Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329-3338.
62. Slack, R.S., Hamel, P.A., Bladon, T.S., Gill, R.M., and McBurney, M.W. (1993). Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 8, 1585-1591.
63. Slansky, J.E., and Farnham, P.J. (1995). Introduction to the E2F family: protein structure and gene regulation. In Transcriptional Control of Cell Growth: the E2F Gene Family, P. Farnham, ed. (New York, New York: Springer-Verlag).
64. Stevens, L.C. (1973). A new inbred strain in mice (129/ter Sv) with a high incidence of spontaneous congenital testicular teratomas. J. Natl. Cancer Inst. 50, 235-242.
65. Turusov, V., and Mohr, U. (1994). Pathology of Tumors in Laboratory Animals (Lyon, France: IARC Scientific Publications).
66. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
67. Vairo, G., Livingston, D.M., and Ginsberg, D. (1995). Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9, 869-881.
68. Wang, T.C., Cardiff, R.D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E.V. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669-671.
69. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
70. Weintraub, S.J., Prater, C.A., and Dean, D.C. (1992). Retinoblastoma protein swithches the E2F site from positive to negative element. Nature 358, 259-261.
71. Weintraub, S.J., Chow, K.N.B., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. (1995). Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812-815.
72. Williams, B.O., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genetics 7, 480-484.
73. ink4a-insensitive cdk4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281-1284.
74. Wu, X., and Levine, A.J. (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602-3606.
75. Xu, M., Sheppard, K.A., Peng, C.Y., Yee, A.S., and Piwnica-Worms, H. (1994). Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14, 8420-8431.
76. Xu, G., Livingston, D.M., and Krek, W. (1995). Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357-1361.